The 21st Century Cures Act provided a billion dollars in new funding for opioid prevention and treatment. In this Wall Street Journal Think Tank column, Drew Altman looks at the challenges based on a new Kaiser-Washington Post survey of long term opioid users.
Featured Opioids Resources
This data note describes uninsured nonelderly adults with opioid use disorder, including their demographic characteristics, health status, and access to treatment.
Issue Brief See More
Related Opioids Resources
- The Role of Community Health Centers in Addressing the Opioid Epidemic
- The Opioid Epidemic and Medicaid’s Role in Facilitating Access to Treatment
- Federal Legislation to Address the Opioid Crisis: Medicaid Provisions in the SUPPORT Act
- How Connecting Justice-Involved Individuals to Medicaid Can Help Address the Opioid Epidemic
- A Look at How the Opioid Crisis Has Affected People with Employer Coverage
- HIV and the Opioid Epidemic: 5 Key Points
- Public Opinion on the Use and Abuse of Prescription Opioids
- Key Healthcare Proposals in Governors’ Proposed Budgets for SFY 2019 from a Preliminary Look at 32 States
- Medicaid and the Opioid Epidemic: Enrollment, Spending, and the Implications of Proposed Policy Changes
- Understanding Who Opioid Users Are Underscores Challenges
- The Washington Post/Kaiser Family Foundation Survey of Long-Term Prescription Painkiller Users and Their Household Members
- 1 in 5 Americans Say They Know Someone Who Has Died from Prescription Painkiller Overdose
- view as grid
- view as list
As the problem of prescription painkiller abuse has captured greater attention from policymakers and the media, the November Kaiser Health Tracking Poll explores the public’s connection to and knowledge of the issue, as well as their views of how to address it. A surprising 56 percent of the public say they have some personal connection to the issue – either because they say they know someone who has taken a prescription painkiller that wasn’t prescribed to them, know someone who has been addicted, or know someone who has died from a prescription painkiller overdose. While views of the health care law have been narrowly divided for much of the year, this month more say they have an unfavorable view of the law than a favorable one. The poll also includes views of the uninsured during the third open enrollment period under the health care law.
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman uses new polling to explore why painkiller abuse and addiction is rising as a health issue among state and federal policymakers. All previous columns by Drew Altman are available online.
The April Kaiser Health Tracking Poll examines the role of health care issues in the presidential election. Health care is one of the top four issues mentioned by voters when asked which issues they most want to hear candidates discuss in the campaign, but half as many cite health care as mention the economy and jobs. It also examines the public’s experiences with prescription painkiller abuse and access to mental health care, as well as their views on efforts to combat painkiller and heroin addiction. It also asks about confidence in the safety of the drinking water supply in the wake of the lead contamination crisis in Flint, Mich., and their views of the government’s performance.
This chart series highlights 5 key things to know about the intersection of the nation’s HIV and opioid epidemics.
Using Medicaid State Drug Utilization Data, this brief presents the 50 most costly drugs before rebates used by the Medicaid program over the January 2014 through June 2015 period. It then examines reasons why these drugs are so costly; explores case studies on opioids, hepatitis C drugs, and the drug Abilify; and considers policy implications.
Most Americans Say Federal and State Governments Are Not Doing Enough to Combat Prescription Painkiller and Heroin Abuse; Large Majorities Believe Wide Range of Strategies Would be Effective
As the White House and Congress continue to debate new funding and other actions to address the nation’s opioid epidemic, the latest Kaiser Health Tracking Poll finds that most Americans believe the federal government is not doing enough to combat the recent increases in the number of people who are…
Medicaid Moving Ahead in Uncertain Times: Results from a 50-State Medicaid Budget Survey for State Fiscal Years 2017 and 2018
This report provides an in-depth examination of the changes taking place in Medicaid programs across the country. Report findings are drawn from the annual budget survey of Medicaid officials in all 50 states and the District of Columbia conducted by the Kaiser Family Foundation (KFF) and Health Management Associates (HMA), in collaboration with the National Association of Medicaid Directors (NAMD). This report examines the reforms, policy changes, and initiatives that occurred in FY 2017 and those adopted for implementation for FY 2018 (which began for most states on July 1, 2017). Key areas covered include changes in eligibility and enrollment, managed care and delivery system reforms, long-term services and supports, provider payment rates and taxes, covered benefits (including prescription drug policies), and opioid harm reduction strategies.
This brief presents the results of the 2018 health center survey questions focused on activities releated to addressing the opioid epidemic. It includes information on opioid use disorder among health center patients, on-site provision of medication-assisted treatment (MAT) and naloxone, provider training on providing MAT, treatment capacity issues, and safe prescribing practices. It also compares activities in Medicaid expansion and non-expansion states and discusses the critical role Medicaid plays in health centers’ ability to address the epidemic.
This brief describes nonelderly adults with opioid use disorder, including their demographic characteristics and insurance status, and compares utilization of treatment services among those with Medicaid to those with other types of coverage. It also describes Medicaid financing for opioid treatment and the ways in which Medicaid promotes access to treatment for enrollees with OUD.